Circulating cytokines in relations to bone mineral density changes in patients with acromegaly

Neuroendocrinology Letters

Volumn 27, Issue 1-2, 2006, Pages 183-188

  Bolanowski, Marek ^a   Daroszewski, Jacek ^a   Zatonska, Katarzyna ^a   Arkowska, Anna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Acromegaly; Bone mineral density; Bone turnover; Cytokines

Indexed keywords

GROWTH HORMONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; SOMATOMEDIN C; TESTOSTERONE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; HUMAN GROWTH HORMONE;

ACROMEGALY; ADULT; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BONE DENSITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITOMETRY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMUR; GONAD FUNCTION; GROWTH HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; RADIUS; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; TESTOSTERONE BLOOD LEVEL; BLOOD; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; RADIODENSITOMETRY; SEXUAL DEVELOPMENT;

ACROMEGALY; ADULT; AGED; BODY MASS INDEX; BONE DENSITY; CYTOKINES; DENSITOMETRY, X-RAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; SEX CHARACTERISTICS; TESTOSTERONE;

EID: 33745652046     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Baldelli R, Dieguez C, Casanueva FF. Acromegaly: from basic research to clinical studies. Endokrynol Pol - Pol J Enclocrinol 2001; 52:57-79.
2. Besedovsky HO, del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 1996; 17:64-102.
3. Bolanowski M, Jedrzejuk D, Milewicz A, Arkowska A. Quantitative ultrasound of the heel and some parameters of bone turnover in patients with acromegaly. Osteoporos Int 2002; 13:303-308.
4. Bolanowski M, Daroszewski J, Medras M, Zadrozna-Sliwka B. Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function. J Bone Miner Metab 2006; 24:72-78.
5. Canalis E. Regulation of bone remodeling. In: Favus MJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. III ed., Philadelphia, Lippincott-Raven; 1996. p. 29-34.
6. Dresner Pollak R, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D. Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol 1998; 93:1483-1490.
7. Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and fraility. Annu Rev Med 2000; 51:245-270.
8. Ezzat S, Forster MJ, Berchtold P, Redelmeier DA, Boerlin V, Harris AG. Acromegaly: clinical and biochemical features in 500 patients. Medicine (Baltimore) 1994; 73:233-240.
9. Grainger DJ, Percival J, Chiano M, Spector TD. The role of serum TGF-β isoforms as potential markers of osteoporosis. Osteoporos Int 1999; 9:398-404.
10. Grey A, Mitnick M-A, Shapses S, Ellison A, Gundberg C, Insogna K. Circulating levels of interleukin-6 and tumor necrosis factor-α are elevated in primary hyperthyroidism and correlate with markers of bone resorption - a clinical research center study. J Clin Endocrinol Metab 1996; 81:3450-3454.
11. Inzucchi SE, Robbins RJ. Effects of growth hormone on human bone biology. J Clin Endocrinol Metab 1994; 79:691-694.
12. Lesse GP Fraser WD, Farquharson R, Hipkin L, Vora JP. Gonadal status is an important determinant of bone density in acromegaly. Clin Endocrinol 1998; 48:59-65.
13. Longobardi S, Di Somma C, Di Rella F, Angelillo N, Ferone D, Colao A, et al. Bone mineral density and circulating cytokines in patients with acromegaly. J Endocrinol Invest 1998; 21:688-693.
14. Manolagas SC. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000; 21:115-137.
15. Mundy G.R. Bone-resorbing cells. In: Favus MJ, editor. Osteoporosis. Fundamentals of clinical practice. Lippincott-Raven, Philadelphia, New York; 1997. p. 17-24.
16. Pfeilschifter J, Koditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 2002; 23:90-119.
17. Roodman GD. Advances in bone biology: the osteoclast. Endocr Rev 1996; 17:308-332.
18. Salamone LM, Whiteside T, Friberg D, Epstein RS, Kuller LH, Cauley JA. Cytokine production and bone mineral density at the lumbar spine and femoral neck in premenopausal women. Calcif Tissue Int 1998; 63:466-470.
19. Scillitani A, Chiodini I, Carnevale V, Giannatempo GM, Frusciante V, Villella M, et al. Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients. J Bone Miner Res 1997; 12:1729-1736.
20. Scheidt-Nave C, Bismar H, Leidig-Bruckner G, Woitge H, Seibel MJ, Ziegler R, et al. Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J Clin Endiocrinol Metab 2001; 86:2032-2042.
21. Silverberg SJ, Locker FG, Bilezikian JP. Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism. J Clin Endocrinol Metab 1996; 81:4007-4012.
22. Zheng SX, Vrindts Y, Lopez M, De Groote D, Zangerle PF, Collette J, et al. Increase in cytokine production (IL-1 beta, IL-6, TNF-alpha but not IFN-gamma, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis. Maturitas 1997; 26:63-71.